DXS LTD has a total of 14 patent applications. Its first patent ever was published in 1998. It filed its patents most often in United Kingdom, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets biotechnology and computer technology are EXACT SCIENCES DEVELOPMENT COMPANY LLC, ADICON CLINICAL LABORATORIES CENTER INC and QIAGEN MANCHESTER LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 3 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Canada | 2 | |
#4 | China | 2 | |
#5 | Brazil | 1 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | Republic of Korea | 1 | |
#8 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Computer technology |
# | Technology | |
---|---|---|
#1 | Measuring microorganism processes | |
#2 | Healthcare informatics | |
#3 | Microorganisms | |
#4 | Electric digital data processing |
# | Name | Total Patents |
---|---|---|
#1 | Ravetto Paul Francis | 8 |
#2 | Thelwell Nicola Jo | 7 |
#3 | Board Ruth | 6 |
#4 | Ferguson Jennifer | 6 |
#5 | Whitcombe David | 6 |
#6 | Whitcombe David Mark | 5 |
#7 | Theaker Jane | 2 |
#8 | Little Stephen | 2 |
#9 | Ruth Board | 2 |
#10 | Francis Ravetto Paul | 2 |
Publication | Filing date | Title |
---|---|---|
GB0719034D0 | Polynucleotide primers | |
GB0523544D0 | A nucleic acid molecule for detecting polymorphisms in the UGT1A1 promoter | |
GB0506807D0 | Polynucleotide primers against epidermal growth factor receptor and method of detecting gene mutations | |
WO02065337A1 | Information repository |